Literature DB >> 6744199

Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women.

M Nielsen, J Jensen, J Andersen.   

Abstract

Among 83 consecutive, unselected female autopsy cases, 6 had been treated for invasive breast carcinoma (IBC) during lifetime. At autopsy, of these six women, two had IBC in the contralateral breast, and another two had in situ carcinoma. Among the 77 women without previous clinical breast cancer, one case of IBC and 14 cases of in situ carcinoma were found at autopsy. Thus, the total occurrence of primary malignant breast lesion was as high as 25.4%. Assuming that all IBCs evolve from in situ forms and that in situ carcinomas do not undergo total regression, our results seem to indicate that about one third of all in situ carcinomas develop into IBC.

Entities:  

Mesh:

Year:  1984        PMID: 6744199     DOI: 10.1002/1097-0142(1984)54:4<612::aid-cncr2820540403>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts.

Authors:  Bernard Junod; Per-Henrik Zahl; Robert M Kaplan; Jørn Olsen; Sander Greenland
Journal:  BMC Cancer       Date:  2011-09-21       Impact factor: 4.430

2.  A Pilot Study of Ultrasound-Guided Cryoablation of Invasive Ductal Carcinomas up to 15 mm With MRI Follow-Up and Subsequent Surgical Resection.

Authors:  Steven P Poplack; Gary M Levine; Lisa Henry; Wendy A Wells; F Scott Heinemann; Cheryl M Hanna; Daniel R Deneen; Tor D Tosteson; Richard J Barth
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

3.  Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions.

Authors:  Helga Bergholtz; Tonje G Lien; David M Swanson; Arnoldo Frigessi; Maria Grazia Daidone; Jörg Tost; Fredrik Wärnberg; Therese Sørlie
Journal:  NPJ Breast Cancer       Date:  2020-06-17

4.  Will screening for breast cancer reduce mortality? Evidence from the first year of screening in Avon.

Authors:  S Nicholson; A J Webb; B Coghlan; J R Farndon; J S Armstrong; J D Davies
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

Review 5.  Recent trends in breast cancer incidence, mortality, and mammography.

Authors:  P A Newcomb; P M Lantz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

6.  The extent and distribution of cancer in breasts with palpable primary tumors.

Authors:  F E Gump; S Shikora; D V Habif; S Kister; P Logerfo; A Estabrook
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

Review 7.  Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer.

Authors:  S R Lakhani
Journal:  Mol Pathol       Date:  2001-10

Review 8.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

9.  Incidence of latent breast cancer in Japanese women.

Authors:  F Akiyama; T Iwase; M Yoshimoto; F Kasumi; G Sakamoto
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.

Authors:  Yunn-Yi Chen; Sandy DeVries; Joseph Anderson; Juan Lessing; Rebecca Swain; Koei Chin; Veronica Shim; Laura J Esserman; Frederic M Waldman; E Shelley Hwang
Journal:  BMC Cancer       Date:  2009-08-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.